Please login to the form below

Article 50

This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.

room visits greater than six hours by 50% and death by 60%.

WHO recommends Valneva’s COVID-19 vaccine for those aged between 18 to 50 years old

The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended Valneva's COVID-19 vaccine – VLA2001 for all individuals aged 18 to 50 years old. ... The vaccine is not recommended for people aged 50 years and avoid,
University of Strathclyde develops pre-clinical screening tool which could increase cancer test numbers by up to 50 times

The University of Strathclyde has developed a screening tool which could increase the number of tests on a solid tumour sample by up to 50 times. ... Our aim is to enable 20 to 50 times more experiments to be performed in these conditions.”.
FDA approves COVID-19 treatment for those under the age of 12

Veklury is approved for temporary use in approximately 50 countries worldwide.
No deal or revoke looming as fourth vote on Brexit nears

So weeks after the EU agreed an extension of Article 50 to 31 October – now just over 160 days away – there seems to have been little progress, despite appeals by President ... Number 10 had been informally saying that if the deals doesn’t get
UK heart deaths rise for first time in 50 years

50 years, warns a new report from charity the British Heart Foundation.

More from news
Approximately 0 fully matching, plus 38 partially matching documents found.

Leave or remain? Winning the employee referendum

killer question: ‘Should I stay or should I go?’ Our decision to trigger the employee equivalent of Article 50 will normally be influenced by our experiences with our current employer. ... We all know you. can’t run a business on 50% turnover, but
The Patient Safety Challenge

The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme
Macron, Merkel and May: implications of the 2017 elections for the life science industry

50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’ transition period
Brexit: the facts (and the alternative facts)

How Brexit affects pharma. The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.
Brexit: Implications for the pharma industry

Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.
50 questions for delivering an exceptional healthcare brand experience

Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need. ... That's why we have created this 50-question checklist to help you deliver an exceptional brand
Random42 Named in Alantra’s Pharma Fast 50.

The London based scientific communication studio have been named in this year’s Pharma Fast 50, an annual ranking of the UK’s fastest-growing companies within the pharmaceutical industry. ... For more on the Pharma Fast 50 read the full article: .
Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research Partnership

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Add my company

Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password: